Welcome to LookChem.com Sign In|Join Free
  • or
6-bromo-2-(4-chlorophenyl)quinazolin-4(3H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

115221-15-3

Post Buying Request

115221-15-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

115221-15-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 115221-15-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,2,2 and 1 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 115221-15:
(8*1)+(7*1)+(6*5)+(5*2)+(4*2)+(3*1)+(2*1)+(1*5)=73
73 % 10 = 3
So 115221-15-3 is a valid CAS Registry Number.

115221-15-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-2-(4-chlorophenyl)quinazolin-4(3H)-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:115221-15-3 SDS

115221-15-3Relevant academic research and scientific papers

Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives

Alafeefy, Ahmed M.,Kadi, Adnan A.,Al-Deeb, Omar A.,El-Tahir, Kamal E.H.,Al-Jaber, Nabila A.

scheme or table, p. 4947 - 4952 (2010/11/20)

Two series of some new 2,4,6-trisubstituted-quinazoline derivatives were prepared and screened for their analgesic, anti-inflammatory activity and acute toxicity. Four compounds were more potent analgesic agents than the reference drug Indomethacin and thirteen compounds showed significant anti-inflammatory activity. Seven compounds showed combined ability to inhibit both pain and inflammation. Compounds tested for acute toxicity showed no toxic symptoms or mortality rates 24 h post-administration implying their good safety margin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 115221-15-3